| Literature DB >> 28912638 |
Rebecca Rachael Lee1,2, Amir Rashid1,2, Daniela Ghio1,2, Wendy Thomson1,2,3, Lis Cordingley1,4.
Abstract
BACKGROUND: Advances in pain assessment approaches now indicate which measures should be used to capture chronic pain experiences in children and adolescents. However, there is little guidance on how these tools should best be administered and reported, such as which time frames to use or how pain scores are categorised as mild, moderate, or severe.Entities:
Mesh:
Year: 2017 PMID: 28912638 PMCID: PMC5585620 DOI: 10.1155/2017/7603758
Source DB: PubMed Journal: Pain Res Manag ISSN: 1203-6765 Impact factor: 3.037
Quality criteria and specifications.
| Requirements to satisfy this criterion: satisfied if | |
|---|---|
|
| |
| (i) Is the tool age appropriate? | (i) VAS used for children 7 and above |
|
| |
| (ii) Were children screened for developmental delay or was a measure of competency conducted prior to pain assessment? | (i) Studies commented upon completing an assessment for delay prior to conducting the study |
|
| |
|
| |
| (i) Did the child have a chance to become familiar with the pain scale used, for example, by rating hypothetical scenarios? | (i) Authors commented upon conducting an assessment of pain prior to the assessment used in the final analysis |
|
| |
| (ii) Did authors identify whether pain measurement captured provoked pain levels or pain levels at rest? | (i) Authors specify the nature of the pain measurement captured; for example, do authors comment upon whether pain assessment encompasses pain levels in provoked situations (activity) or unprovoked ones (at rest)? |
|
| |
| (iii) Was the child the main reporter of pain at assessment? | (i) Authors explicitly stated that children completed the scale or questionnaire independently |
|
| |
| (iv) Were successive pain ratings observed? | (i) Authors described taking more than one assessment of pain |
|
| |
| (v) Were consistent verbal anchors used across patients in the same study? | (i) Authors described the anchors used |
|
| |
|
| |
| (i) Was a narrative explanation of pain scores also obtained, at least at the first data collection point? | (i) Authors explicitly stated that a narrative was gained as part of the pain assessment |
|
| |
|
| |
| (i) Was the temporal frame for pain ratings reported? | (i) Authors state the time scale used to frame pain assessments |
|
| |
| (ii) Were the authors clear about which type of pain was measured? | (i) Authors describe the type of pain reported, for example, worst, least, and most pain |
Figure 1PRISMA flow diagram of study selection process.
Reasons for exclusion of studies after full-text review of eligibility.
| Reason | Number of studies |
|---|---|
| Not in the defined age bracket (or does not describe age of children/adolescents) | 30 |
| Not chronic pain | 21 |
| No measure of pain | 6 |
| Review or prevalence study | 9 |
| Pain assessment tool not described | 3 |
| Qualitative study | 1 |
| Duplicate | 2 |
Figure 2Quality scores against criteria.
Study characteristics and quality assessments by two independent reviewers.
| Tool | Author and year | Chronic pain condition |
| Mean age (years) | SD (years) | Female | Range | Quality score |
|---|---|---|---|---|---|---|---|---|
| VAS | Abu-Saad and Uiterwijk (1995) [ | Juvenile rheumatoid arthritis | 33 | — | — | 72.3% | 7–16 | 5 |
| VAS | Astfalck et al. (2010) [ | Chronic low back pain | 28 | 15.55 | 0.5 | 50% | 14–16 | 1 |
| VAS | Chan et al. (2009) [ | Chronic daily headache | 12 | — | — | — | 14–18 | 2 |
| VAS | Cohen et al. (2010) [ | Chronic pain | 222 | 14.8 | 1.9 | 74.6% | 10–18 | 5 |
| VAS | de Oliveira et al. (2011) [ | Juvenile idiopathic arthritis | 80 | 11.6 | — | 42% | 8–14 | 2 |
| VAS | Eccleston et al. (2004) [ | Chronic pain | 80 | 14.45 | 1.55 | 71.25% | 11–17 | 5 |
| VAS | Gold et al. (2009) [ | Chronic pain | 80 | 13.89 | 2.57 | 72.5% | 8–18 | 5 |
| VAS | Gragg et al. (1996) [ | Rheumatic disease | 100 | 12.2 | 2.49 | 68% | 8–16 | 5 |
| VAS | Guite et al. (2011) [ | Chronic pain | 259 | 15.10 | 1.64 | 77.6% | 12–18 | 5 |
| VAS | Hunfeld et al. (2002) [ | Chronic pain | 42 | 14.5 | 1.6 | — | 12–18 | 7 |
| VAS | Hunfeld et al. (2002) [ | Chronic pain | 85 | 8.4 | 2.25 | 65.88% | 5–11 | 5 |
| VAS | Jacob et al. (2012) [ | Sickle cell disease | 31 | 13.4 | 2.4 | 51.6% | 10–17 | 6 |
| VAS | Kashikar-Zuck et al. (2011) [ | Chronic pain | 1300 | 14.2 | 2.4 | 76% | 8–18 | 5 |
| VAS | Kashikar-Zuck et al. (2012) [ | Juvenile fibromyalgia | 114 | 15 | 1.8 | 92.1% | 11–18 | 4 |
| VAS | Konijnenberg et al. (2005) [ | Chronic pain | 149 | 11.8 | — | 73% | 8–18 | 5 |
| VAS | Logan et al. (2006) [ | Chronic pain | 112 | 15.3 | 1.3 | 79.46% | 13–18 | 3 |
| VAS | Lynch et al. (2006) [ | Chronic back pain | 65 | 14.9 | 2.6 | 80% | 8–18 | 6 |
| VAS | Schanberg et al. (2003) [ | Polyarticular arthritis | 41 | 12.3 | 2.9 | 59% | 8–17 | 5 |
| VAS | Stinson et al. (2008) [ | Juvenile idiopathic arthritis | 112 | 13 | 2.45 | — | 8–17 | 6 |
| VAS | Stinson et al. (2013) [ | Cancer | 47 | 13.4 | — | — | 9–18 | 6 |
| VAS | Swain et al. (2005) [ | Juvenile fibromyalgia | 22 | 15.62 | 1.33 | 100% | 13–17 | 5 |
| VAS | Varni et al. (1987) [ | Juvenile rheumatoid arthritis | 25 | 9.5 | 3.17 | 76% | 5–15 | 7 |
| VAS | Vervoort et al. (2008) [ | Chronic pain | 71 | 13.33 | 2.83 | 57.38% | 8–18 | 4 |
| VAS | Vetter et al. (2014) [ | Chronic Pain | 99 | 13.2 | 2.4 | 71% | 8–17 | 5 |
| NRS | Claar et al. (2008) [ | Chronic pain | 254 | 14.69 | 1.49 | 76.8% | 12–17 | 6 |
| NRS | Cornelissen et al. (2014) [ | Juvenile idiopathic arthritis | 60 | 13 | — | 73% | 7–17 | 5 |
| NRS | Guite et al. (2011) [ | Chronic pain | 259 | 15.10 | 1.64 | 77.6% | 12–18 | 5 |
| NRS | Hainsworth et al. (2007) [ | Chronic pain | 60 | 14.0 | 2.7 | 81.7% | 8–18 | 5 |
| NRS | Hainsworth et al. (2009) [ | Chronic pain | 319 | 13.4 | 2.7 | 71% | 8–18 | 4 |
| NRS | Hechler et al. (2014) [ | Chronic pain | 87 | 14 | 3.4 | 74.66% | 9–17 | 6 |
| NRS | Hicks et al. (2006) [ | Chronic pain | 47 | 11.7 | 2.1 | 63.83 | 9–16 | 4 |
| NRS | Hirschfeld et al. (2013) [ | Chronic pain | 167 | 14.1 | 1.91 | 62% | 11–18 | 6 |
| NRS | Hirschfeld et al. (2013) [ | Chronic pain | 2249 | 12.45 | 2.93 | 61% | — | 2 |
| NRS | Jastrowski et al. (2013) [ | Chronic pain | 6 | 15 | — | — | 12–17 | 4 |
| NRS | Logan et al. (2008) [ | Chronic pain | 414 | 14.7 | 1.6 | 75.6% | 12–17 | 4 |
| NRS | Logan et al. (2013) [ | Chronic pain | 614 | 13.88 | — | 74.73% | 7–18 | 5 |
| NRS | Palermo et al. (2008) [ | Chronic pain | 155 | 14.31 | 2.45 | 58.06% | 8–18 | 5 |
| NRS | Ruskin et al. (2014) [ | Chronic pain | 143 | 14.1 | 2.4 | 72% | 8–17 | 6 |
| NRS | Ruskin et al. (2015) [ | Chronic pain | 16 | 15.75 | 1.00 | 100% | 13–17 | 5 |
| NRS | Simons et al. (2010) [ | Chronic pain | 126 | 15 | 1.5 | 82.5% | 12–17 | 5 |
| NRS | Simons et al. (2015) [ | Chronic pain | 321 | 13.73 | 2.47 | 74.8% | 8–18 | 5 |
| NRS | Smith et al. (2015) [ | Chronic pain | 310 | 13.80 | 2.69 | 75.2% | 8–17 | 5 |
| NRS | Vowles et al. (2010) [ | Chronic pain | 209 | 14.8 | 1.9 | 74.6% | 10–18 | 5 |
| FPS | Claar and Walker (2006) [ | Chronic abdominal pain | 596 | 11.59 | 2.45 | 61% | 8–17 | 5 |
| FPS | Palermo et al. (2004) [ | Chronic pain | 189 | 12.4 | 2.5 | 60% | 8–16 | 4 |
| FPS | Palermo and Kiska (2005) [ | Chronic pain | 86 | 14.75 | — | 67% | 13–16 | 4 |
| FPS-revised | Hechler et al. (2014) [ | Chronic pain | 87 | 14 | 3.4 | 74.66% | 9–17 | 6 |
| FPS-revised | Kashikar-Zuck et al. (2011) [ | Chronic pain | 1300 | 14.2 | 2.4 | 76% | 8–18 | 6 |
| FPS-revised | Ramstad et al. (2011) [ | Cerebral palsy | 153 | 14.27 | 2.88 | 47.06% | 8–18 | 7 |
|
| ||||||||
|
|
| |||||||
|
| ||||||||
|
|
| |||||||
|
| ||||||||
|
|
| |||||||
|
| ||||||||
|
|
| |||||||
|
| ||||||||
|
|
| |||||||
Descriptive information of VAS studies.
| VAS study authors | Age range (mean) | Children completed assessment | Completed with clinician | Parents completed assessment | Person completing not described | Highest anchor | Classification details provided | Successive ratings gained | Reference time period |
|---|---|---|---|---|---|---|---|---|---|
| Abu-Saad and Uiterwijk (1995) [ | 7–16 | ✓ | ✓ | I have very severe pain | X | No | Present and worst pain | ||
| Astfalck et al. (2010) [ | 14–16 (15.55) | X | X | X | X | Current pain | |||
| Chan et al. (2009) [ | 14–18 | X | X | X | Yes | X | |||
| Cohen et al. (2010) [ | 10–18 (14.8) | ✓ | Worst pain possible | X | No | Typical pain over the past week | |||
| de Oliveira et al. (2011) [ | 8–14 | ✓ | Very severe pain | X | No | X | |||
| Eccleston et al. (2004) [ | 11–17 (14.45) | ✓ | ✓ | Worst pain possible | X | No | Average pain intensity over the previous week | ||
| Gold et al. (2009) [ | 8–18 (13.89) | ✓ | Worst pain imaginable | X | No | Pain over the past month | |||
| Gragg et al. (1996) [ | 8–16 | ✓ | ✓ | Hurting a whole lot or | X | Yes | Present and worst pain intensity for the previous week | ||
| Guite et al. (2011) [ | 12–18 (15.10) | ✓ | Unbearable pain | X | Yes | Most, usual, and least pain | |||
| Hunfeld et al. (2002) [ | 12–18 (14.5) | ✓ | Worst pain imaginable | X | Yes | Pain at that moment | |||
| Hunfeld et al. (2002) [ | 5–11 | ✓ | Worst pain imaginable | X | Yes | Pain at that moment | |||
| Jacob et al. (2012) [ | 10–17 | X | Worst pain | X | No | Current, worst, and least pain in the last 12 hours | |||
| Kashikar-Zuck et al. (2011) [ | 8–18 | ✓ | Worst imaginable pain | X | No | Highest, lowest, and average pain | |||
| Kashikar-Zuck et al. (2012) [ | 11–18 | X | Worst possible pain | X | Yes | Average pain severity | |||
| Konijnenberg et al. (2005) | 8–18 | X | Worst pain possible | X | No | Current pain level and highest pain in days preceding | |||
| Logan et al. (2006) [ | 13–18 | ✓ | ✓ | X | X | X | Most, usual, and least pain | ||
| Lynch et al. (2006) [ | 8–18 | ✓ | Worst imaginable pain | X | No | Highest, lowest, and average in the last two weeks | |||
| Schanberg et al. (2003) [ | 8–17 | ✓ | Hurting a whole lot or | X | Yes | Daily pain intensity | |||
| Stinson et al. (2008) [ | 8–17 | ✓ | Very much pain | X | Yes | Current, least, average, and worst pain intensity | |||
| Stinson et al. (2013) [ | 9–18 | ✓ | Worst possible pain | X | Yes | How much pain you have right now | |||
| Swain et al. (2005) [ | 13–17 | ✓ | ✓ (psychologist) | Worst imaginable pain | X | No | Highest, lowest, and average in the last two weeks | ||
| Varni et al. (1987) [ | 5–15 (9.5) | ✓ | ✓ (paediatric rheumatologist) | ✓ | Hurting a whole lot or | X | No | Present pain and worst pain intensity for the previous week | |
| Vervoort et al. (2008) [ | 8–18 | ✓ | ✓ (psychologist) | A lot of pain | X | No | Most severe and present pain | ||
| Vetter et al. (2014) [ | 8–17 | ✓ | ✓ | Hurting a whole lot or | X | No | Pain at the present time and at its worst in the past week |
Note. “X” signifies details not reported.
Descriptive information of NRS studies.
| NRS study authors | Age range (mean) | Children completed assessment | Completed with clinician | Parents completed assessment | Person completing not described | Highest anchor | Classification details provided | Successive ratings gained | Reference time period |
|---|---|---|---|---|---|---|---|---|---|
| Claar et al. (2008) [ | 12–17 (14.69) | ✓ | ✓ (psychologist) | Most pain possible | X | No | Current pain rating | ||
| Cornelissen et al. (2014) [ | 7–17 | ✓ | Worst pain imaginable | X | No | On the day of the study | |||
| Guite et al. (2011) [ | 12–18 (15.10) | ✓ | Worst pain imaginable | X | No | Current, most, usual, and least pain | |||
| Hainsworth et al. (2007) [ | 8–18 (14.0) | ✓ | ✓ | Worst pain experienced | X | No | Intensity of pain over the past two weeks | ||
| Hainsworth et al. (2009) [ | 8–18 | ✓ | ✓ | Worst pain experienced | X | No | Best, worst, and usual pain | ||
| Hechler et al. (2014) [ | 9–17 | ✓ | ✓ | X | X | Yes | Average of the last seven days | ||
| Hicks et al. (2006) [ | 9–16 | ✓ | Worst pain | X | Yes | X | |||
| Hirschfeld et al. (2013) [ | 11–18 (14.1) | ✓ | Maximal pain | ✓ | Yes | Mean intensity in the past seven days | |||
| Hirschfeld et al. (2013) [ | Range not given | X | X | ✓ | No | Maximal pain during the past four weeks | |||
| Jastrowski et al. (2013) [ | 12–17 | X | Worst pain | X | Yes | Pain over the prior two weeks | |||
| Logan et al. (2008) [ | 12–17 (14.7) | ✓ | ✓ (psychologist) | Most pain possible | X | No | Current, lowest, and highest pain ratings | ||
| Logan et al. (2013) [ | 7–18 (13.88) | ✓ | ✓ (psychologist) | Most pain possible | X | No | Current pain at rest | ||
| Palermo et al. (2008) [ | 8–18 (14.31) | ✓ | Worst pain ever | X | No | Average or usual pain | |||
| Ruskin et al. (2014) [ | 8–17 | ✓ | ✓ (anaesthesiologist) | The strongest or worst pain you can imagine | X | No | Current, usual, lowest, and strongest | ||
| Ruskin et al. (2015) [ | 13–17 (15.75) | ✓ | Worst pain imaginable | X | No | Average, worst, and lowest pain | |||
| Simons et al. (2010) [ | 12–17 (14.8) | ✓ | ✓ (type of clinician unclear) | Most pain possible | X | No | Current pain rating | ||
| Simons et al. (2015) [ | 8–18 | ✓ | ✓ (psychologist) | Most pain possible | X | No | Average pain rating | ||
| Smith et al. (2015) [ | 8–17 (range not given) | ✓ | ✓ (psychologist) | Most pain possible | X | No | Average daily pain rating | ||
| Vowles et al. (2010) [ | 10–18 (14.8) | ✓ | Worst possible pain | X | No | Average/usual pain over the last week |
Note. “X” signifies details not reported.
Descriptive information of FPS studies.
| FPS study authors | Age range (mean) | Children completed assessment | Completed with clinician | Parents completed assessment | Person completing not described | Highest anchor | Classification details provided | Successive ratings gained | Reference time period |
|---|---|---|---|---|---|---|---|---|---|
| Original Faces Pain Scale (Bieri et al., 1990) [ | |||||||||
| Claar and Walker (2006) [ | 8–17 (11.59) | ✓ | X | X | No | Usual level | |||
| Palermo et al. (2004) [ | 8–16 | ✓ | ✓ | Worst pain | X | No | Over the previous four weeks | ||
| Palermo and Kiska (2005) [ | 13–16 (14.75) | ✓ | Worst pain ever | X | No | Pain during the previous four weeks | |||
|
| |||||||||
| Faces Pain Scale Revised (Hicks et al., 2001) [ | |||||||||
| Hechler et al. (2014) [ | 9–17 | ✓ | ✓ | X | X | Yes | Average of the last seven days | ||
| Kashikar-Zuck et al. (2011) [ | 8–18 | ✓ | X | X | No | Maximum intensity over the last month | |||
| Ramstad et al. | 8–18 (14.27) | ✓ | ✓ (paediatrician or physiotherapist) | X | X | No | Maximum intensity over the last month | ||
Note. “X” signifies details not reported.